Epidemiological and pathobiological profiles of Clostridium perfringens infections: review of consecutive series of 33 cases over a 13-year period. 2015

Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
Department of Gastroenterology, Saitama Medical Center, Jichi Medical University Japan.

BACKGROUND Although Clostridium perfringens (C. perfringens) is well known as the causative agent of several forms of enteric disease, precise epidemiological and pathobiological aspects are still unknown. METHODS We retrospectively reviewed the culture results of samples collected in our hospital from 2001 through 2013. In addition, for the detection and toxinogenic typing of C. perfringens, polymerase-chain-reaction amplification (PCR)-based rapid analysis was performed in 6 cases using DNA extracted from paraffin-embedded tissues. RESULTS A total of 35 samples from 33 cases were positive for C. perfringens, representing an incidence of 0.017% (35/205, 114). Among 33 patients, 21 patients manifested sepsis and 7 patients had bacteremia. One of the septic cases was complicated by fatal intravascular hemolysis and thus, the prevalence was estimated at 3.0% among C. perfringens infections (1/33). The direct causative disease or state for C. perfringens infection was identified in 18 patients: surgery or intervention for cancers, 8 patients; chemotherapy for cancer, 2 patients; surgery or intervention for non-neoplastic disease, 6 patients; liver cirrhosis, 3 patients, etc. PCR-based toxinogenic typing of C. perfringens detected the alpha-toxin gene only in tissue from a patient who died of massive hemolysis; none of the toxin genes could be amplified in the other 5 cases examined. CONCLUSIONS The prevalence of overt C. perfringens infection is low, but upon detection, infected patients should be carefully monitored for fatal acute hemolysis caused by type A C. perfringens. Furthermore, PCR-based rapid detection of C. perfringens and toxinogenic typing by archival pathological material is applicable as a diagnostic tool.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003016 Clostridium perfringens The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins. Clostridium welchii
D005260 Female Females
D005738 Gas Gangrene A severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases (over eighty percent), while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases. Gangrene, Gas,Gangrenes, Gas,Gas Gangrenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
March 1978, The Journal of the Kentucky Medical Association,
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
January 2010, Internal medicine (Tokyo, Japan),
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
January 1981, Lijecnicki vjesnik,
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
January 1981, The Journal of bone and joint surgery. American volume,
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
June 1981, The Journal of hospital infection,
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
September 2020, Avian diseases,
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
January 2011, Journal of forensic sciences,
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
May 2012, Musculoskeletal surgery,
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
July 2020, International journal of environmental research and public health,
Yuji Shindo, and Yoh Dobashi, and Toshiyasu Sakai, and Chie Monma, and Hiroyuki Miyatani, and Yukio Yoshida
October 2021, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!